References
- . Davis AE III. New treatments addressing the pathophysiology of hereditary angioedema. Clin Mol Allergy. 2008;6:2
- . Papadopoulou–Alataki E. Upper airway considerations in hereditary angioedema. Curr Opin Allergy Clin Immunol. 2010;10(1):20–25
- . Zuraw BL. Hereditary angioedema. N Engl J Med. 2008;359(10): 1027–1036
- . Bernstein JA. Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies. Ann Allergy Asthma Immunol. 2008;100( suppl 2):S41–S46
- . Agostoni A, Aygoren–Pursun E, Binkley KE, . Hereditary and acquired angioedema: problems and progress-proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114( 3 suppl):S51–S131
- . C1 Inhibitor Gene Mutation Database. National Medical Center, Laboratory of Molecular Biology. http://hae.enzim.hu. Accessed April 24, 2012
- . Prada AE, Zahedi K, Davis AE 3rd. Regulation of C1 inhibitor synthesis. Immunobiology. 1998;199(2):377–388
- . Binkley KE, Davis A 3rd. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol. 2000;106(3):546–550
- . Bork K, Gul D, Dewald G. Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men. Br J Dermatol. 2006;154(3):542–545
- . Bork K, Meng G, Stauback P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs and course. Am J Med. 2006;119(3):267–274
- . Farkas H, Jakab L, Temesszentandrasi G, . Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol. 2007;120(4):941–947
- . Kemp JG, Craig TJ. Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature review. Allergy Asthma Proc. 2009;30(5):493–499
- . Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am. 2006;26(4):653–668
- . Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin North Am. 2006;26(4):709–724
- . Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976;84(5):580–593
- . Weis M. Clinical review of hereditary angioedema: diagnosis and management. Postgrad Med. 2009;121(6):113–121
- . Gompels MM, Lock RJ, Abinun M, . C1 inhibitor deficiency: consensus document. Clin Exp Immunol. 2005;139(3):379–394
- . Bork K, Siedlecki K, Bosch S, . Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc. 2000;75(4):349–354
- . Craig TJ, Levy RJ, Wasserman RL, . Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol. 2009;124(4):801–808
- . Craig TJ. Appraisal of danazol prophylaxis for hereditary angioedema. Allergy Asthma Proc. 2008;29(3):225–231
- . Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol. 2006;117(4):904–908
- . Cinryze [package insert]. Exton, PA: ViroPharma; 2008
- . Sondhi D, Lippmann M, Murali G. Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital. Chest. 2004;126(2):400–404
- . Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf. 1998;18(3):171–188
- . Bas M, Hoffmann T, Kojda G. Evaluation and management of angioedema of the head and neck. Curr Opin Otolaryngol Head Neck Surg. 2006;14(3):170–175
- . Korniyenko A, Alviar CL, Cordova JP, Messerli FH. Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy. Cleve Clin J Med. 2011;78(5):297–304
- . Winters M. Clinical practice guideline: Initial evaluation and management of patients presenting with acute urticaria or angioedema (7/10/06). Milwaukee, WI: American Academy of Emergency Medicine; Jul 10, 2006. http://www.aaem.org/positionstatements/clinical_practice_guidelines.php. Accessed February 23, 2010
- . Bowen T, Cicardi M, Bork K, . Hereditary angioedema: a current state-of-the-art review, VII: Canadian Hungarian 2007 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. Ann Allergy Asthma Immunol. 2008;100( suppl 2):S30–S40
- . Pekdemir M, Ersel M, Aksay E, . Effective treatment of hereditary angioedema with fresh frozen plasma in an emergency department. J Emerg Med. 2007;33(2):137–139
- . Prematta M, Gibbs JG, Pratt EL, . Fresh frozen plasma for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol. 2007;98(4):383–388
- . Frank MM, Jiang H. New therapies for hereditary angioedema: disease outlook changes dramatically. J Allergy Clin Immunol. 2008;121(1):272–280
- . Prematta MJ, Prematta T, Craig TJ. Treatment of hereditary angioedema with plasma-derived C1 inhibitor. Ther Clin Risk Manage. 2008;4(5):975–982
- . Berinert® [C1 Esterase Inhibitor (Human)] [package insert]. Marburg, Germany: CSL Behring GmbH; December, 2011
- . Craig TJ, Bewtra AK, Bahna SL, . C1 esterase inhibitor concentrate in 1085 hereditary angioedema attacks—final results of the I.M.P.A.C.T.2 study. Allergy 2011;66(12):1604–1611
- . Bork K, Meng G, Stauback P, Hardt J. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion. 2005;45(11):1774–1784
- . Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med. 2001;161(5):714–718
- . De Serres J, Gröner A, Lindner J. Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert) in hereditary angioedema: a review. Transfus Apher Sci. 2003;29(3):247–254
- . Kalbitor [package insert]. Cambridge, MA: Dyax Corp; 2009
- . Levy R, McNeil D, Li H, . Results of a 2-stage, phase 3 pivotal trial EDEMA3: a study of subcutaneous DX-88 (ecallantide), a plasma kallikrein inhibitor, in patients with hereditary angioedema (HAE). J Allergy Clin Immunol. 2008;121(2 suppl 1):S231
- . Lunn M, Banta E. Ecallantide for the treatment of hereditary angioedema in adults. Clin Med Insights Cardiol. 2011;5:49–54
- . Levy R, Lumry WR, McNeil DL, . EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. Ann Allergy Asthma Immunol. 2010;104(6):523–529
- . Firazyr [package insert]. Lexington, MA: Shire Orphan Therapeutics, Inc; 2011
- . Cicardi M, Banerji A, Bracho F, . Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med. 2010;363(6):532–541
- . Lumry WR, Li HH, Levy RJ, . Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment fo acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol. 2011;107(6):529–537
- . Longhurst HJ. Management of acute attacks of hereditary angioedema: potential role of icatibant. Vasc Health Risk Manag. 2010;6: 795–802
- . Choi G, Soeters MR, Farkas H, . Recombinant human C1-inhibitor in the treatment of acute angioedema attacks. Transfusion. 2007;47(6):1028–1032
- . Nuijens J, Verdonk R, Giannetti B, . Clinical studies of recombinant human c1 inhibitor (rhC1INH) in patients with acute attacks of hereditary angioedema. J Allergy Clin Immunol. 2008;121(3):797
- . Sardana N, Craig TJ. Recent advances in management and treatment of hereditary angioedema. Pediatrics. 2011;128(6):1173–1180
- . Varga L, Farkas H. rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency. Expert Rev Clin Immunol. 2011;7(2):143–153
- . Kreuz W, Rusicke E, Martinez–Saguer I, . Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema. Transfusion. 2012;52(1):100–107
- . Tourangeau LM, Castaldo AJ, Davis DK, Koziol J, Christiansen SC, Zuraw BL. Safety and efficacy of physician-supervised self-managed C1 inhibitor replacement therapy. Int Arch Allergy Immunol. 2012;157(4):417–424
- . Banerji A, Sheffer AL. The spectrum of chronic angioedema. Allergy Asthma Proc. 2009;30(1):11–16